Great news - drug with direct effect on malignant cells

The experts from Australia have improved the technology for cytostatics to have direct effect on malignant cells. The method is based on nanotechnology. Thus, nanocell with the cytostatic for hemotherapy, by means of antibodies on its surface, leads required substances to the cancer cells and hook them onto the cells. The cancer cells are then closing around them and the drug goes directly into their interior.

This method would make it possible for thousand times smaller doses to be used in conventional hemotherapy.

Prior to the end of year 2007, the new drug will be tested on humans.